Migraine Patch on Hold for Now
Teva Pharmaceuticals has suspended sales, marketing and distribution for now for the Zecuity (sumatriptan iontophoretic transdermal system) patch.
Got Migraines? Check Your Heart
Women who have been diagnosed with migraines may have a slightly raised risk of heart disease events and heart-related death, a new study found.
FDA Approves Multiple Sclerosis Rx
The US Food and Drug Administration has approved a new treatment for relapsing forms of multiple sclerosis.
Yoga May Go to Your Head
Besides stress reduction, improved flexibility and exercise, yoga may provide another health benefit, a new study found.
Another Danger of Pesticides
Environmental toxins, such as certain pesticides, may be tied to an increased risk for a serious neurodegenerative disease, a new study found.
A Pain Rx That Resists Abuse
The US Food and Drug Administration (FDA) has approved a new opioid with abuse-deterrent properties.
Nuplazid Gets FDA Go-Ahead
The US Food and Drug Administration (FDA) has approved Nuplazid (pimavanserin) tablets to treat hallucinations and delusions in patients with Parkinson's disease.
Seizure Rx May Cut Dosing in Half
Who wants to take medication twice a day when you can take it once a day?
Antipsychotics for Parkinson's: The Problem
Physicians commonly prescribe antipsychotic drugs to treat psychosis associated with Parkinson's. However, a new study published in JAMA Neurology suggests that these drugs may be causing additional harm.
Stay Active to Stay Sharp
Need another reason to exercise? Reducing your risk of Alzheimer's may be as simple as working in the garden or taking a walk each day.